Q1 2023 Coloplast A/S Earnings Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by. Welcome, and thank you for joining the Coloplast's Q1 2022/'23 Earnings Release Conference Call. (Operator Instructions)
It's my pleasure, and I would now like to turn the conference over to Kristian Villumsen, President and CEO. Please go ahead, sir.
/-&
Good morning, and welcome to our Q1 '22/'23 conference call. I'm Kristian Villumsen, CEO of Coloplast, and I'm joined by our CFO, Anders Lonning-Skovgaard and our investor Relations team. We'll start with a short presentation by Anders and myself and then open up for questions like we usually do.
Please turn to Slide #3. We delivered 7% organic growth and a 29% EBIT margin before special items. Return on invested capital after tax and before special items was 20%, impacted by the Atos Medical acquisition. I'm satisfied with the solid start to the year. We continue to outgrow the market across regions and help more people with
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
